Phosphorylation of the nuclear form of varicella-zoster virus immediate-early protein 63 by casein kinase II at serine 186

Journal of Virology

Volumn 83, Issue 23, 2009, Pages 12094-12100

  Mueller, Niklaus H ^a   Graf, Laurie L ^a   Orlicky, David ^a   Gilden, Don ^a   Cohrs, Randall J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 63; MONOCLONAL ANTIBODY; MUTANT PROTEIN; NUCLEAR PROTEIN; SERINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VARICELLA ZOSTER VIRUS; VIRUS LATENCY; VIRUS REACTIVATION;

ANTIBODIES, VIRAL; CASEIN KINASE II; CELL LINE; CELL NUCLEUS; HERPESVIRUS 3, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; SERINE; VIRAL ENVELOPE PROTEINS;

HUMAN HERPESVIRUS 3;

EID: 70450195207     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01526-09     Document Type: Article

References (38)

1. Ambagala, A. P., T. Bosma, M. A. Ali, M. Poustovoitov, J. J. Chen, M. D. Gershon, P. D. Adams, and J. I. Cohen. 2009. Varicella-zoster virus immediate- early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3.1 and h3.3. J. Virol. 83:200-209.
2. Baiker, A., C. Bagowski, H. Ito, M. Sommer, L. Zerboni, K. Fabel, J. Hay, W. T. Ruyechan, and A. M. Arvin. 2004. The immediate-early 63 protein of varicella-zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. J. Virol. 78:1181-1194. (Pubitemid 38095828)
3. Barbas, C. F., III, A. S. Kang, R. A. Lerner, and S. J. Benkovic. 1991. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. USA 88:7978-7982.
4. Bontems, S., E. Di Valentin, L. Baudoux, B. Rentier, C. Sadzot-Delvaux, and J. Piette. 2002. Phosphorylation of varicella-zoster virus IE63 protein by casein kinases influences its cellular localization and gene regulation activity. J. Biol. Chem. 277:21050-21060.
5. Burton, D. R., C. F. Barbas III, M. A. Persson, S. Koenig, R. M. Chanock, and R. A. Lerner. 1991. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88:10134-10137.
6. Cohen, J. I., T. Krogmann, S. Bontems, C. Sadzot-Delvaux, and L. Pesnicak. 2005. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for replication in vitro are also critical for efficient establishment of latency. J. Virol. 79:5069-5077.
7. Cohrs, R. J., and D. H. Gilden. 2003. Varicella zoster virus transcription in latently-infected human ganglia. Anticancer Res. 23:2063-2069. (Pubitemid 36897165)
8. Cohrs, R. J., and D. H. Gilden. 2007. Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia. J. Virol. 81:2950-2956.
9. Cohrs, R. J., M. Barbour, and D. H. Gilden. 1996. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol. 70:2789-2796.
10. Cohrs, R. J., J. Wischer, C. Essman, and D. H. Gilden. 2002. Characterization of varicella-zoster virus gene 21 and 29 proteins in infected cells. J. Virol. 76:7228-7238.
11. Cohrs, R. J., S. K. Mehta, D. S. Schmid, D. H. Gilden, and D. L. Pierson. 2008. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J. Med. Virol. 80:1116-1122.
12. Cohrs, R. J., D. H. Gilden, P. R. Kichington, E. Grinfield, and P. G. Kennedy. 2003. Varicella-zoster virus gene 66 transcription and translation in latently infected human ganglia. J. Virol. 77:6660-6665.
13. Debrus, S., C. Sadzot-Delvaux, A. F. Nikkels, J. Piette, and B. Rentier. 1995. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J. Virol. 69:3240-3245.
14. Ellis, F., and B. A. Stoll. 1949. Herpes zoster after irradiation. Br. Med. J. 2:1323-1328.
15. Gilden, D. H., R. J. Cohrs, and R. Mahalingam. 2003. Clinical and molecular pathogenesis of varicella virus infection. Viral Immunol. 16:243-258. (Pubitemid 37229539)
16. Grinfeld, E., and P. G. Kennedy. 2004. Translation of varicella-zoster virus genes during human ganglionic latency. Virus Genes 29:317-319. (Pubitemid 40941264)
17. Habran, L., S. Bontems, E. Di Valentin, C. Sadzot-Delvaux, and J. Piette. 2005. Varicella-zoster virus IE63 protein phosphorylation by roscovitinesensitive cyclin-dependent kinases modulates its cellular localization and activity. J. Biol. Chem. 280:29135-29143.
18. Issinger, O. G. 1993. Casein kinases: pleiotropic mediators of cellular regulation. Pharmacol. Ther. 59:1-30.
19. Kennedy, P. G., E. Grinfeld, and J. W. Gow. 1999. Latent varicella-zoster virus in human dorsal root ganglia. Virology 258:451-454.
20. Kennedy, P. G., E. Grinfeld, and J. E. Bell. 2000. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J. Virol. 74: 11893-11898.
21. Kennelly, P. J., and E. G. Krebs. 1991. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266:15555-15558.
22. Kenyon, T. K., J. Lynch, J. Hay, W. Ruyechan, and C. Grose. 2001. Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J. Virol. 75:8854-8858.
23. Kolappaswamy, K., R. Mahalingam, V. Traina-Dorge, S. T. Shipley, D. H. Gilden, B. K. Kleinschmidt-DeMasters, C. G. McLeod, Jr., L. L. Hungerford, and L. J. DeTolla. 2007. Disseminated simian varicella virus infection in an irradiated rhesus macaque (Macaca mulatta). J. Virol. 81:411-415.
24. Lungu, O., P. W. Annunziato, A. Gershon, S. M. Staugaitis, D. Josefson, P. LaRussa, and S. J. Silverstein. 1995. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc. Natl. Acad. Sci. USA 92:10980-10984.
25. Lungu, O., C. A. Panagiotidis, P. W. Annunziato, A. A. Gershon, and S. J. Silverstein. 1998. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. USA 95:7080-7085.
26. Mahalingam, R., M. Wellish, R. Cohrs, S. Debrus, J. Piette, B. Rentie, and D. H. Gilden. 1996. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc. Natl. Acad. Sci. USA 93:2122-2124.
27. Mahalingam, R., M. Wellish, T. White, K. Soike, R. Cohrs, B. K. Kleinschmidt-DeMasters, and D. H. Gilden. 1998. Infectious simian varicella virus expressing the green fluorescent protein. J. Neurovirol. 4:438-444. (Pubitemid 28395725)
28. Mahalingam, R., V. Traina-Dorge, M. Wellish, R. Lorino, R. Sanford, E. P. Ribka, S. J. Alleman, E. Brazeau, and D. H. Gilden. 2007. Simian varicella virus reactivation in cynomolgus monkeys. Virology 368:50-59. (Pubitemid 47599561)
29. McManaman, J. L., W. Zabaronick, J. Schaack, and D. J. Orlicky. 2003. Lipid droplet targeting domains of adipophilin. J. Lipid Res. 44:668-673.
30. Mehta, S. K., R. J. Cohrs, B. Forghani, G. Zerbe, D. H. Gilden, and D. L. Pierson. 2004. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J. Med. Virol. 72:174-179.
31. Mueller, N. H., L. L. Graf, A. J. Shearer, G. P. Owens, D. H. Gilden, and R. J. Cohrs. 2008. Construction of recombinant mouse IgG1 antibody directed against varicella zoster virus immediate early protein 63. Hybridoma 27:1-10.
32. Sarno, S., B. Boldyreff, O. Marin, B. Guerra, F. Meggio, O. Issinger, and L. A. Pinna. 1995. Mapping the residues of protein kinase CK2 implicated in substrate recognition: mutagenesis of conserved basic residues in the alphasubunit. Biochem. Biophys. Res. Commun. 206:171-179.
33. Schoeb, T. R., R. Eberle, D. H. Black, R. F. Parker, and S. C. Cartner. 2008. Diagnostic exercise: papulovesicular dermatitis in rhesus macaques (Macaca mulatta). Vet. Pathol. 45:592-594.
34. Sokal, J. E., and D. Firat. 1965. Varicella-zoster infection in Hodgkin's disease: clinical and epidemiological aspects. Am. J. Med. 39:452-463.
35. Stevenson, D., M. Xue, J. Hay, and W. T. Ruyechan. 1996. Phosphorylation and nuclear localization of the varicella-zoster virus gene 63 protein. J. Virol. 70:658-662. (Pubitemid 126508842)
36. Theil, D., T. Derfuss, I. Paripovic, S. Herberger, E. Meinl, O. Schueler, M. Strupp, V. Arbusow, and T. Brandt. 2003. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163:2179-2184.
37. Walters, M. S., C. A. Kyratsous, S. Wan, and S. Silverstein. 2008. Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner. J. Virol. 82:8673-8686.
38. Yamane, K., and T. J. Kinsella. 2005. CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. Cancer Res. 65:4362-4367. (Pubitemid 40775675)